|
|||||
|
|
Near real‐time adverse drug reaction surveillance within population‐based health networks: methodology considerations for data accrual |
|
| Authors: | Taliser R. Avery Martin Kulldorff Yury Vilk Lingling Li T. Craig Cheetham Sascha Dublin Robert L. Davis Liyan Liu Lisa Herrinton Jeffrey S. Brown |
| Abstract: | |
| Keywords: | drug surveillance prospective analysis analytic methods pharmacoepidemiology |